HEMORRHAGIC COMPLICATIONS OF PERCUTANEOUS INTERVENTIONS FOR NEPHROLITHIASIS


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Hemorrhagic complications are one of the major problems of percutaneous urolithiasis interventions. Aim. To investigate the incidence of hemorrhagic complications after percutaneous nephrolithotripsy. Material and methods. This was a comparative analysis of 146 percutaneous nephrolithotripsies. The study group comprised 81 patients with stag horn nephrolithiasis; the rest of the patients were assigned to the control group. Results. Both groups were comparable in age and sex (p>0.05). The body weight of the patients in the study group was statistically significantly higher than in the control group, amounting to 94.1±15.4 and 68.3±9.6 kg, respectively (p<0.05), the body mass index in the study group averaged 45.9±7.6 kg/m2 versus 28.5±9.4 kg/m2 in the control group (p<0.05). 50.6% of the study group patients had urate urolithiasis. The blood loss depended on operative time and the number of accesses to the kidney. The incidence of hemorrhagic complications did not differ in both groups and was in the range of 16 to 16.9% (p> 0.05). Early hemorrhagic complications did not exceed Grade II, according to Clavien-Dindo classification. Anticoagulant and antiplatelet therapy did not increase the number of hemorrhagic complications. Arterial hypertension was the main risk factor for hemorrhagic complications. Conclusion. Arterial hypertension in patients scheduled for percutaneous nephrolithotripsy should be corrected. To stop ongoing renal bleeding, image-guided endovascular interventions should be used.

Full Text

Restricted Access

About the authors

S. V Shkodkin

St. Ioasaf Belgorod Regional Hospital; Belgorod State National Research University

Email: shkodkin-s@mail.ru
Dr.Med.Sci., Urologist at the Department of Urology; Professor at the Department of Surgery, Medical Institute

Yu. B Idashkin

St. Ioasaf Belgorod Regional Hospital

Physician of the Highest Category, Urologist at the Consultative Outpatient Clinic

V. N Dmitriev

Belgorod State National Research University

Email: vadd@mail.ru
Ph.D., Associate Professor at the Department of Surgery, Medical Institute

A. V Lyubushkin

Belgorod State National Research University

Email: 360298458@bk.ru
Ph.D. Student at the Department of Surgery, Medical Institute

A. A Nevskii

Belgorod State National Research University

Email: nevskiy_101@mail.ru
Resident at the Department of Surgery, Medical Institute

References

  1. Shoag J., Tasian G.E., GoldfarbD.S., EisnerB.H. The new epidemiology of nephrolithiasis. Adv Chronic Kidney Dis. 2015;22(4):273-278.
  2. Stamatelou K.K., Francis M.E., Jones C.A. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int. 2003;63(5):1817-1823.
  3. Hesse A., Brandle E., Wilbert D. et al. Study on the prevalence and incidence of urolithiasis in Germany comparing the years 1979 vs. 2000. Eur Urol. 2003;44(6):709-713.
  4. Sanchez-Martin F.M., Millan Rodriguez F., Esquena Fernández S. Incidence and prevalence of published studies about urolithiasis in Spain. A review. Actas Urol Esp. 2007;31(5):511-520.
  5. Yasui T., Okada A., Usami M. et al. Association of the loci 5q35.3, 7q14.3, and 13.q14.1 with urolithiasis: A case-control study in the Japanese population. J Urol. 2013;189(4 Suppl.):e854.
  6. Apolikhin O.I., Sivkov A.V., Solntseva T.V., Komarova V.A. Epidemiology of urolithiasis in various regions of the Russian Federation. Byulleten’ meditsinskikh internet-konferentsii. 2011; 1(3): 167-76.
  7. Yanenko E.K., Merinov D.S., Konstantinova O.V., Epishov V.A., Kalinichenko D.N. Current trends in the epidemiology, diagnosis and treatment of urolithiasis. Eksperimental’naya i klinicheskaya urologiya. 2012;3:19-25.
  8. Barbera M., Tsirgiotis A., Barbera M., Paola Q. The importance of potassium citrate and potassium bicarbonate in the treatment of uric acid renal stones. Arch Ital Urol Androl. 2016;88(4):341-342.
  9. Spivacow F.R., Del Valle E.E., Lores E., Rey P.G. Kidney stones: Composition, frequency and relation to metabolic diagnosis. Medicina (B Aires). 2016;76(6):343-348.
  10. Shestaev A.Yu., Paronnikov M.V., Protoshchak V.V., Kormakov V.A., Babkin P.A., Kukushkin A.V., Kushnirenko N.P. Metaphylaxis ofoxadate urolythiasis in patients with metabolic syndrome. Eksperimental’naya i klinicheskaya urologiya. 2014;3:53-56.
  11. Avdoshin V.P., Andryukhin M.I., Israfilov M.N., Annenkov A.V., Atamanova E.A. Treatment and metaphylaxis of urate and mixed urolithiasis. Urologiia. 2012;3:7-10.
  12. Cherepanova E.V., Dzeranov N.K. Metaphylaxis of urolithiasis in outpatient settings. Eksperimental’naya i klinicheskaya urologiya. 2010;3:33-39.
  13. Kok D.J. Metaphylaxis, diet and lifestyle in stone disease. Arab J Urol. 2012;10(3):240-249.
  14. Menditto V.G., Milanese G., Muzzonigro G. Metaphylaxis ofurolithiasis. Arch Ital Urol Androl. 2009;81(1):32-39.
  15. Isaenko V.I., Feofilov I.V. Current surgery of nephrolithiasis. Meditsina i obrazovanie v Sibiri. 2015;3:64-71.
  16. Türk C., Petrik A., Sarica K., Seitz C., Skolarikos A., Straub M., Knoll T. EAU Guidelines on Interventional Treatment for Urolithiasis. Eur Urol. 2016;69(3):475-482.
  17. Mishra S., Sabnis R.B., Desai M.R. Percutaneous nephrolithotomymonotherapy for staghorn: paradigm shift for ‘staghornmorphometry’ based clinical classification. Curr Opin Urol. 2012;22(2):148-153.
  18. Alyaev Yu.G., Grigor’ev N.A. Surgical treatment of stag horn nephrolithiasis. Saratovskii nauchno-meditsinskii zhurnal. 2011;7(S2): 112-14.
  19. Feofilov I.V. To the surgery of stag horn nephrolithiasis. Meditsina i obrazovanie v Sibiri. 2015;4:18-25.
  20. Amosov N.A., Urenkov S.B., Ivanov A.E., Podoinitsyn A.A. Place of retrograde nephrolithotripsy in the treatment of patients with stag horn nephrolithiasis. Eksperimental’naya i klinicheskaya urologiya. 2015;4:100-03.
  21. Perepechai V.A., Zozulya A.V., Skorikov I.I., Dimitriadi S.N., Gornostaev V.N. Comparative effectiveness of combination of contact transurethral and percutaneous lithotripsy with remote lithotripsy in the treatment of stag horn nephrolithiasis. Klinicheskaya praktika. 20111(5):31
  22. Nasirov F.R., Mirkhamidov D.Kh., Alidzhanov Zh.F., Giyasov Sh.I., Nuraliev T.Yu., Yuldashev Zh.M., Mukhtarov Sh.T., Akilov F.A. Evaluation of the effectiveness of multi-access percutaneous endoscopic treatment in patients with stag horn and multiple nephrolithiasis. Eksperimental’naya i klinicheskaya urologiya 2014 4:60-63.
  23. Khasigov A.V., Kogan M.I., BelousovI.I. Management of patients with stag horn nephrolithiasis. Vladikavkazskii mediko-biologicheskii vestnik. 2011 ;XIII(20-21):86-94
  24. Khasigov A.V., Kogan M.I., BelousovI.I. Management of patients with stag horn nephrolithiasis. Vladikavkazskii mediko-biologicheskii vestnik. 2011 ;XIII(20-21):86-94
  25. Golovanov S.A., Sivkov A.V., Anokhin N.V., Drozhzheva V.V. The prevalence of metabolic types of urolithiasis in the Moscow region. Comparative analysis for the period from 2010 to 2013. Eksperimental’naya i klinicheskaya urologiya. 2014;4:54-57
  26. Sasaki Y., Kohjimoto Y., Iba A., Matsumura N., Hara I. Weight loss intervention reduces the risk of kidney stone formation in a rat model of metabolic syndrome. Int J Urol. 2015;22(4):404-409.
  27. Cormio L., Gonzalez G.I., Tolley D., Sofer M., Muslumanoglu A., Klingler H.C., Stolzenburg J.U. Exit strategies following percutaneous nephrolithotomy (PCNL): a comparison of surgical outcomes in the Clinical Research Office of the Endourological Society (CROES) PCNL Global Study. J. World J Urol. 2013;31(5):1239-1244.
  28. Sorokin N.I. Superselective occlusion of the renal arteries. Dr.Med.Sci. Thesis. M., 2016. 47 p.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies